National Comprehensive Cancer Network

About NCCN

NCCN Flash Updates: NCCN Guidelines® & NCCN Templates® Updated

NCCN has published updates to the following NCCN Chemotherapy Order Template (NCCN Templates®) for Neuroendocrine Tumors of the Pancreas.

  • The cycle definition reflected on the following template has changed from “6-week cycle: 4 weeks on followed by 2 weeks off treatment then repeated until disease progression or unacceptable toxicity” to “28-day cycle until disease progression or unacceptable toxicity” to reflect the currently published NCCN Guidelines for Neuroendocrine Tumors, Version 3.2017:
    • NEUP6 - Sunitinib

 

NCCN has published updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) and NCCN Drugs & Biologics Compendium (NCCN Compendium®) for Malignant Pleural Mesothelioma. These NCCN Guidelines® are currently available as Version 2.2017.

  • Principles of Systemic Therapy (MPM-A 1 of 2)
    • Second-line Chemotherapy changed to Subsequent Systemic Therapy
      • Nivolumab ± ipilimumab added as a treatment option.
      • Pembrolizumab added as a treatment option.
      • References 16 and 17 added.

*For your reference, the previous update (Version 1.2017) to the NCCN Guidelines for Malignant Pleural Mesothelioma, published on March 2, 2017 is available at the following link: https://www.nccn.org/professionals/physician_gls/pdf/mpm.pdf

For the complete updated versions of the NCCN Guidelines, NCCN Guidelines with NCCN Evidence Blocks™, the NCCN Drugs & Biologics Compendium (NCCN Compendium®), the NCCN Biomarkers Compendium®, the NCCN Templates®, and the NCCN Imaging Appropriate Use Criteria (NCCN Imaging AUC™), please visit NCCN.org.

To view the NCCN Guidelines for Patients®, please visit NCCN.com/patients.

Free NCCN Guidelines apps for iPhone, iPad, and Android tablets are now available! Visit NCCN.org/apps

About NCCN Flash Updates™ 
NCCN Flash Updates™ is a subscription service from NCCN that provides timely notification of updated and new information appearing in the NCCN Guidelines, the NCCN Compendium®, and other NCCN Content. 

Subscribe to NCCN Flash Updates™ 

National Comprehensive Cancer Network® (NCCN®)
275 Commerce Drive, Suite 300
Fort Washington, PA 19034
Telephone: +1 215.690.0300 Fax: +1 215.690.0280 

Access information on permissions and licensing of NCCN Content